|
Volumn 17, Issue 15, 2008, Pages 944-949
|
Managing patients with metastatic colorectal cancer on bevacizumab.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
CLINICAL TRIAL;
COLORECTAL TUMOR;
HUMAN;
METASTASIS;
NURSING;
PATHOLOGY;
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS AS TOPIC;
COLORECTAL NEOPLASMS;
HUMANS;
NEOPLASM METASTASIS;
|
EID: 58149184535
PISSN: 09660461
EISSN: None
Source Type: Journal
DOI: 10.12968/bjon.2008.17.15.30695 Document Type: Review |
Times cited : (17)
|
References (47)
|